Temporospatial patterns of COX-2 expression and pyramidal cell degeneration in the rat hippocampus after trimethyltin administration

Neuroscience Research

Volumn 59, Issue 2, 2007, Pages 117-123

  Shirakawa, Takafumi ^a,b   Nakano, Kenji ^a   Hachiya, Naomi S ^b   Kato, Nobumasa ^c   Kaneko, Kiyotoshi ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

CA1; CA3; Cyclooxygenase 2 (COX 2); Neuronal degeneration; Plasma corticosterone concentration; Trimethyltin (TMT)

Indexed keywords

CORTICOSTERONE; CYCLOOXYGENASE 2; TRIMETHYLTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HIPPOCAMPUS; HISTOPATHOLOGY; HORMONE SYNTHESIS; LOCOMOTION; MALE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; TEMPORAL CORTEX;

ANIMALS; CELL SURVIVAL; CORTICOSTERONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENCEPHALITIS; HIPPOCAMPUS; HYPERKINESIS; MALE; NERVE DEGENERATION; ORGANIC CHEMICALS; PYRAMIDAL CELLS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS; TRIMETHYLTIN COMPOUNDS;

EID: 34548787848     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.06.1468     Document Type: Article

References (43)

1. Arias-Negrete S., Keller K., and Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem. Biophys. Res. Commun. 208 2 (1995) 582-589
2. Baik E.J., Kim E.J., Lee S.H., and Moon C. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res. 843 1/2 (1999) 118-129
3. Bouldin T.W., Goines N.D., Bagnell R.C., and Krigman M.R. Pathogenesis of trimethyltin neuronal toxicity. Ultrastructural and cytochemical observations. Am. J. Pathol. 104 3 (1981) 237-249
4. Candore G., Balistreri C.R., Grimaldi M.P., Vasto S., Listi F., Chiappelli M., Licastro F., Lio D., and Caruso C. Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. Ann. N. Y. Acad. Sci. 1089 (2006) 472-486
5. Casolini P., Catalani A., Zuena A.R., and Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J. Neurosci. Res. 68 3 (2002) 337-343
6. Chang L.W., and Dyer R.S. A time-course study of trimethyltin induced neuropathology in rats. Neurobehav. Toxicol. Teratol. 5 4 (1983) 443-459
7. Choi J.S., Kim H.Y., Chun M.H., Chung J.W., and Lee M.Y. Differential regulation of cyclooxygenase-2 in the rat hippocampus after cerebral ischemia and ischemic tolerance. Neurosci. Lett. 393 2/3 (2006) 231-236
8. Dash P.K., Mach S.A., and Moore A.N. Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury. J. Neurotrauma 17 1 (2000) 69-81
9. Dayton E.T., and Major E.O. Recombinant human interleukin 1 beta induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures. J. Neuroimmunol. 71 1/2 (1996) 11-18
10. Dyer R.S., Deshields T.L., and Wonderlin W.F. Trimethyltin-induced changes in gross morphology of the hippocampus. Neurobehav. Toxicol. Teratol. 4 2 (1982) 141-147
11. Gobbo O.L., and O'Mara S.M. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience 125 2 (2004) 317-327
12. Govoni S., Masoero E., Favalli L., Rozza A., Scelsi R., Viappiani S., Buccellati C., Sala A., and Folco G. The cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci. Lett. 303 2 (2001) 91-94
13. Harry G.J., Tyler K., d'Hellencourt C.L., Tilson H.A., and Maier W.E. Morphological alterations and elevations in tumor necrosis factor-alpha, interleukin (IL)-1alpha, and IL-6 in mixed glia cultures following exposure to trimethyltin: modulation by proinflammatory cytokine recombinant proteins and neutralizing antibodies. Toxicol. Appl. Pharmacol. 180 3 (2002) 205-218
14. Hayley S., Brebner K., Lacosta S., Merali Z., and Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 19 13 (1999) 5654-5665
15. Ikeda M., Kanai H., Akaike M., Tsutsumi S., Sadamatsu M., Masui A., and Kato N. Nitric oxide synthase-containing neurons in the hippocampus are preserved in trimethyltin intoxication. Brain Res. 712 1 (1996) 168-170
16. Imai H., Kabuto M., Takita M., and Kato N. Interleukin-1 receptor antagonist inhibits transient increase of plasma corticosterone in the initial phase of trimethyltin-induced hippocampal necrosis. Neurotoxicology 19 1 (1998) 163-166
17. Imai H., Nishimura T., Sadamatsu M., Liu Y., Kabuto M., and Kato N. Type II glucocorticoid receptors are involved in neuronal death and astrocyte activation induced by trimethyltin in the rat hippocampus. Exp. Neurol. 171 1 (2001) 22-28
18. Ishida N., Akaike M., Tsutsumi S., Kanai H., Masui A., Sadamatsu M., Kuroda Y., Watanabe Y., McEwen B.S., and Kato N. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience 81 4 (1997) 1183-1191
19. Ishikura N., Tsunashima K., Watanabe K.I., Nishimura T., Shirayama Y., and Kato N. Temporal change of hippocampal enkephalin and dynorphin mRNA following trimethyltin intoxication in rats: effect of anticonvulsant. Neurosci. Lett. 306 3 (2001) 157-160
20. Kawaguchi K., Hickey R.W., Rose M.E., Zhu L., Chen J., and Graham S.H. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res. 1050 1/2 (2005) 130-137
21. Kim D.K., and Jang T.J. Cyclooxygenase-2 expression and effect of celecoxib in flurothyl-induced neonatal seizure. Int. J. Exp. Pathol. 87 1 (2006) 73-78
22. Kim Y.S., and Joh T.H. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp. Mol. Med. 38 4 (2006) 333-347
23. Kim H.C., Jhoo W.K., Bing G., Shin E.J., Wie M.B., Kim W.K., and Ko K.H. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 874 1 (2000) 15-23
24. Koistinaho J., Koponen S., and Chan P.H. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. Stroke 30 9 (1999) 1900-1906
25. Kunz T., Marklund N., Hillered L., and Oliw E.H. Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat. J. Neurotrauma 19 9 (2002) 1051-1064
26. Kunz T., Marklund N., Hillered L., and Oliw E.H. Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat. Restor. Neurol. Neurosci. 24 1 (2006) 55-63
27. Linthorst A.C., Flachskamm C., Holsboer F., and Reul J.M. Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology 135 2 (1994) 520-532
28. Liu Y., Imai H., Sadamatsu M., Tsunashima K., and Kato N. Cytokines participate in neuronal death induced by trimethyltin in the rat hippocampus via type II glucocorticoid receptors. Neurosci. Res. 50 2 (2004) 209-217
29. Matsuoka Y., Okazaki M., Zhao H., Asai S., Ishikawa K., and Kitamura Y. Phosphorylation of c-Jun and its localization with heme oxygenase-1 and cyclooxygenase-2 in CA1 pyramidal neurons after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 19 11 (1999) 1247-1255
30. Melik Parsadaniantz S., Dauge V., Roques B.P., and Kerdelhue B. Acute intrahippocampal injection of human interleukin-1beta stimulates the anterior pituitary POMC transcription and increases plasma levels of ACTH and corticosterone in the male rat. Neuroendocrinology 69 2 (1999) 77-87
31. Nishimura T., Schwarzer C., Furtinger S., Imai H., Kato N., and Sperk G. Changes in the GABA-ergic system induced by trimethyltin application in the rat. Brain Res. Mol. Brain Res. 97 1 (2001) 1-6
32. Nogawa S., Zhang F., Ross M.E., and Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17 8 (1997) 2746-2755
33. Robertson D.G., Gray R.H., and de la Iglesia F.A. Quantitative assessment of trimethyltin induced pathology of the hippocampus. Toxicol. Pathol. 15 1 (1987) 7-17
34. Ruppert P.H., Walsh T.J., Reiter L.W., and Dyer R.S. Trimethyltin-induced hyperactivity: time course and pattern. Neurobehav. Toxicol. Teratol. 4 2 (1982) 135-139
35. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 2 (2000) 123-130
36. Swanson L.W. Brain Maps: Structure of the Rat Brain (1992), Elsevier Science Publishers BV
37. Takemiya T., Maehara M., Matsumura K., Yasuda S., Sugiura H., and Yamagata K. Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neurosci. Res. 56 1 (2006) 103-110
38. Tsunashima K., Sadamatsu M., Takahashi Y., Kato N., and Sperk G. Trimethyltin intoxication induces marked changes in neuropeptide expression in the rat hippocampus. Synapse (New York, NY) 29 4 (1998) 333-342
39. Tsutsumi S., Akaike M., Arimitsu H., Imai H., and Kato N. Circulating corticosterone alters the rate of neuropathological and behavioral changes induced by trimethyltin in rats. Exp. Neurol. 173 1 (2002) 86-94
40. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Ann. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
41. Wang Q., Tang X.N., and Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 184 1-2 (2007) 53-68
42. Woodruff M.L., Baisden R.H., Whittington D.L., Shelton N.L., and Wray S. Grafts containing fetal hippocampal tissue reduce activity and improve passive avoidance in hippocampectomized or trimethyltin-exposed rats. Exp. Neurol. 102 1 (1988) 130-143
43. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 2 (1993) 371-386